High ankle-brachial index, a marker of arterial stiffness, may be used to assess the risk for cardiovascular autonomic neuropathy in type 1 diabetes.
Transgender women receiving hormone replacement therapy may be at an increased risk for thromboembolism, though data and recommendations vary across studies.
From 2011 to 2015, there was a decline in the rates of delayed discharge following transcatheter aortic valve replacement.
The clinical outcomes of patients undergoing transcarotid transcatheter aortic valve replacement with the Edwards Sapien 3 device were examined.
Trimetazidine therapy did not improve exercise capacity in symptomatic nonobstructive cardiomyopathy.
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.
A pooled analysis of patient data analyzed the safety and efficacy of stenting and endarterectomy for symptomatic carotid stenosis.
The incidence of venous thromboembolism or death due to venous thromboembolism during 180 days is not significantly reduced for rivaroxaban compared with placebo.
Patients with injection drug use-related endocarditis are more likely to be readmitted with endocarditis, septicemia, and drug abuse.
Older patients with severe frailty undergoing TAVR and SAVR frequently experience subsequent functional decline or lack of improvement.